Grothey A - Search Results

1

Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7.

Grothey A, Nikcevich DA, Sloan JA, Kugler JW, Silberstein PT, Dentchev T, Wender DB, Novotny PJ, Chitaley U, Alberts SR, Loprinzi CL. Grothey A, et al. J Clin Oncol. 2011 Feb 1;29(4):421-7. doi: 10.1200/JCO.2010.31.5911. Epub 2010 Dec 28. J Clin Oncol. 2011. PMID: 21189381 Free PMC article. Clinical Trial.

2

Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment.

Grothey A, Sargent D, Goldberg RM, Schmoll HJ. Grothey A, et al. J Clin Oncol. 2004 Apr 1;22(7):1209-14. doi: 10.1200/JCO.2004.11.037. J Clin Oncol. 2004. PMID: 15051767

3

Oxaliplatin plus oral fluoropyrimidines in colorectal cancer.

Grothey A, Goetz MP. Grothey A, et al. Clin Colorectal Cancer. 2004 Jun;4 Suppl 1:S37-42. doi: 10.3816/ccc.2004.s.006. Clin Colorectal Cancer. 2004. PMID: 15212704 Review.

4

A review of oxaliplatin and its clinical use in colorectal cancer.

Grothey A, Goldberg RM. Grothey A, et al. Expert Opin Pharmacother. 2004 Oct;5(10):2159-70. doi: 10.1517/14656566.5.10.2159. Expert Opin Pharmacother. 2004. PMID: 15461551 Review.

5

Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates.

Folprecht G, Grothey A, Alberts S, Raab HR, Köhne CH. Folprecht G, et al. Among authors: grothey a. Ann Oncol. 2005 Aug;16(8):1311-9. doi: 10.1093/annonc/mdi246. Epub 2005 May 3. Ann Oncol. 2005. PMID: 15870084 Free article.

6

Clinical management of oxaliplatin-associated neurotoxicity.

Grothey A. Grothey A. Clin Colorectal Cancer. 2005 Apr;5 Suppl 1:S38-46. doi: 10.3816/ccc.2005.s.006. Clin Colorectal Cancer. 2005. PMID: 15871765 Review.

7

FOLFOX for stage II colon cancer? A commentary on the recent FDA approval of oxaliplatin for adjuvant therapy of stage III colon cancer.

Grothey A, Sargent DJ. Grothey A, et al. J Clin Oncol. 2005 May 20;23(15):3311-3. doi: 10.1200/JCO.2005.11.691. J Clin Oncol. 2005. PMID: 15908645 No abstract available.

8

N0147: a randomized phase III trial of oxaliplatin plus 5-fluorouracil/leucovorin with or without cetuximab after curative resection of stage III colon cancer.

Alberts SR, Sinicrope FA, Grothey A. Alberts SR, et al. Among authors: grothey a. Clin Colorectal Cancer. 2005 Sep;5(3):211-3. doi: 10.3816/ccc.2005.n.033. Clin Colorectal Cancer. 2005. PMID: 16197625 Clinical Trial. No abstract available.

9

Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials.

Sargent DJ, Wieand HS, Haller DG, Gray R, Benedetti JK, Buyse M, Labianca R, Seitz JF, O'Callaghan CJ, Francini G, Grothey A, O'Connell M, Catalano PJ, Blanke CD, Kerr D, Green E, Wolmark N, Andre T, Goldberg RM, De Gramont A. Sargent DJ, et al. Among authors: grothey a. J Clin Oncol. 2005 Dec 1;23(34):8664-70. doi: 10.1200/JCO.2005.01.6071. Epub 2005 Oct 31. J Clin Oncol. 2005. PMID: 16260700

10

Is there a third-line therapy for metastatic colorectal cancer?

Grothey A. Grothey A. Semin Oncol. 2006 Dec;33(6 Suppl 11):S36-8. doi: 10.1053/j.seminoncol.2006.10.007. Semin Oncol. 2006. PMID: 17178284 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

381 results

Search Page

Filters